↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Portugal BASE contract award · ocds-ted-230920-2026

Portugal – Pharmaceutical products – Aquisiçao do Medicamento: Axicabtagene ciloleucel 0.4 - 2 x10e8 células Disp inj Fr

Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. awarded €5.5M to GILEAD SCIENCES, LDA for Construction & Public Works in April 2026 — one of 76 awards this buyer has made, above its typical award size.

Construction & Public Works
03 Apr 2026
Award date
€5.5M
Contract value

Buying agency

Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E.
76 Awards
€9.9M Avg award
Above vs typical

Winning supplier

GILEAD SCIENCES, LDA
65 Awards
4 Buyers
€30.7M Total won

Contract description

Portugal – Pharmaceutical products – Aquisiçao do Medicamento: Axicabtagene ciloleucel 0.4 - 2 x10e8 células Disp inj Fr 68 ml IV

Premium

Related awards · Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E.

76 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

32 more awards from this buyer · full history & CSV export

Premium

Other wins · GILEAD SCIENCES, LDA

65 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. and GILEAD SCIENCES, LDA — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up